跳至主要内容
临床试验/JPRN-UMIN000005724
JPRN-UMIN000005724招募中2 期

Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome endocrinopathy (ROSE Trial) - Rheumatoid Arthritis with Orencia Trial Toward Sjogren's syndrome endocrinopathy (ROSE Trial)

Division of Clinical Immunology, Major of Advanced Biochemical Applications, Graduate School of Comprehensive Human Science,University of Tsukuba Takayuki Sumida0 个研究点目标入组 30 人开始时间: 2011年6月29日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)contraindicated patients 2)patients over 75 years of age 3)Patients with a total leukocyte count of 3000/mm3 or less, 4)pregnant women or lactating mothers, women with child-bearing potential and patients wishing to become pregnant during this study 5)patients under 20 years of age 6)patients who had received any drugs for treatment of Sjogren's syndrome, including cevimeline hydrochloride hydrate, anetholtrithion, and pilocarpine hydrochloride within 4 weeks prior to the study treatment 7) patients with any concurrent serious disorders of the liver, kidney or hematopoietic organs 8) anti centromere antibody positive 9)Patients who are inadequate by investigator's decision.

研究者

发起方
Division of Clinical Immunology, Major of Advanced Biochemical Applications, Graduate School of Comprehensive Human Science,University of Tsukuba Takayuki Sumida

相似试验

Rheumatoid Arthritis with Orencia Trial Toward... | 临床试验